Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Prof Anders Bjartell discusses the data sources and access of the PIONEER data models

Prof Anders Bjartell - Skåne University Hospital, Malmö, Lund University, Sweden
Prof Anders Bjartell discusses the data sources and access of the PIONEER data models ( Prof Anders Bjartell - Skåne University Hospital, Malmö, Lund University, Sweden )
13 May 2019

Future directions in glioblastoma: the potential role of TKIs

Prof Roger Stupp, Dr Giuseppe Lombardi
Future directions in glioblastoma: the potential role of TKIs ( Prof Roger Stupp, Dr Giuseppe Lombardi )
9 May 2019

Optimum duration of adjuvant treatment of stage III colorectal cancer: 3 versus 6 months

Prof John Marshall - Georgetown University Hospital, Washington D.C., USA
Optimum duration of adjuvant treatment of stage III colorectal cancer: 3 versus 6 months ( Prof John Marshall - Georgetown University Hospital, Washington D.C., USA )
9 May 2019

State of art in systemic management of nmCRPC

Prof Stéphane Oudard - Georges Pompidou Hospital, Paris, France
State of art in systemic management of nmCRPC ( Prof Stéphane Oudard - Georges Pompidou Hospital, Paris, France )
8 May 2019

First- and second-line treatments for locally advanced renal cell carcinoma

Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA
First- and second-line treatments for locally advanced renal cell carcinoma ( Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA )
8 May 2019

Surgical management of pancreatic cancer

Prof Ibrahim Al-Sheneber - Saudi Cancer Foundation, Khobar, Saudi Arabia
Surgical management of pancreatic cancer ( Prof Ibrahim Al-Sheneber - Saudi Cancer Foundation, Khobar, Saudi Arabia )
8 May 2019

Advanced HCC: New systemic treatment options

Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt
Advanced HCC: New systemic treatment options ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )
8 May 2019

Highlights from IGILUC 2019

Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt
Highlights from IGILUC 2019 ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )
8 May 2019

PARP inhibitors and their side effects in solid tumour therapy

Paula Anastasia - David Geffen School of Medicine at UCLA Los Angeles, USA
PARP inhibitors and their side effects in solid tumour therapy ( Paula Anastasia - David Geffen School of Medicine at UCLA Los Angeles, USA )
8 May 2019

Treating ovarian cancer patients with PARP inhibitors

Kimberly Halla - Arizona Oncology Associates PC, Scottsdale, USA
Treating ovarian cancer patients with PARP inhibitors ( Kimberly Halla - Arizona Oncology Associates PC, Scottsdale, USA )
8 May 2019

Benefits and challenges of using PARP inhibitors to treat metastatic breast cancer

Kimberly Halla - Arizona Oncology Associates PC, Scottsdale, USA
Benefits and challenges of using PARP inhibitors to treat metastatic breast cancer ( Kimberly Halla - Arizona Oncology Associates PC, Scottsdale, USA )
8 May 2019

Benefits of cannabis legalisation to patients and oncology professionals

Eloise Theisen - Radicle Health, Walnut Creek, USA
Benefits of cannabis legalisation to patients and oncology professionals ( Eloise Theisen - Radicle Health, Walnut Creek, USA )
8 May 2019